Introduction: Ixekizumab is a biologic agent primarily indicated for the treatment of moderate to-severe plaque psoriasis. This study aimed to evaluate the post-marketing safety profile of ixekizumab ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A Freedom to Read sign is placed inside the ʻEwa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback